Power to the people
29 Jun 2010
The coalition’s recently unveiled Programme for Government and proposals for a new Health Bill promise significant change for the NHS. Patient power, value-based pricing and clinical leadership will be take centre stage. But what will it mean for pharma? Chris Ross examines the rhetoric.
Read More